Myriad Genetics sell JPMorgan Chase & Co.
Start price
07.11.23
/
50%
€16.70
Target price
07.11.24
€13.08
Performance (%)
10.78%
Price
02.05.24
€18.10
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 10.78%. This prediction currently runs until 07.11.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Myriad Genetics | 9.581% | 9.581% |
iShares Core DAX® | 0.000% | -2.064% |
iShares Nasdaq 100 | 0.626% | -2.884% |
iShares Nikkei 225® | 1.568% | -5.892% |
iShares S&P 500 | 0.334% | -2.281% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Myriad Genetics diskutieren
Myriad Genetics, Inc. (NASDAQ: MYGN) had its price target lowered by analysts at JPMorgan Chase & Co. from $17.00 to $14.00. They now have an "underweight" rating on the stock.
Ratings data for MYGN provided by MarketBeat